Ralph Jordan is a serial entrepreneur and strategic advisor with over 30 years of healthcare leadership. As the founder of Trident Health Resources, he redefined cardiovascular perfusion services nationwide—culminating in a successful acquisition by SpecialtyCare in 2017.
His ventures span surgical technology, biotech, and regenerative medicine, including being one of the founders of Cryo-Cell International. Today, Ralph advises Kensington Park Capital, one of America’s Top 50 M&A Investment Bankers, serves on the advisory board of Florida Trust Wealth Management, serves on the Advisory board of International Prostate Cancer Foundation, and is on the Advisory Board of the Frostburg State University School of Business, Engineering, Computing, and Analytics.